Home › Funds › Cormorant Asset Management, LP › INBX
Cormorant Asset Management, LP position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Cormorant Asset Management, LP reported holding 50,000 shares of INBX (INHIBRX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.36% of its reported portfolio and ranking #39 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's INBX position evolved
Cormorant Asset Management, LP first disclosed a stake in INBX in Q3 2026 at 50,000 shares (US$5.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 50.00K | $5.00M | New |
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC) is a Health Care company. 40 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$129.3M), Sanofi (US$115.9M), Schonfeld Strategic Advisors LLC (US$82.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.29M sh · $129.35M · Q3 2026
- Sanofi 1.16M sh · $115.89M · Q3 2026
- Schonfeld Strategic Advisors LLC 827.28K sh · $82.79M · Q3 2026
- Sofinnova Investments, Inc. 391.62K sh · $39.19M · Q3 2026
- Parkman Healthcare Partners LLC 360.26K sh · $36.05M · Q3 2026
- PFM Health Sciences, LP 320.33K sh · $32.06M · Q3 2026
- Soleus Capital Management, L.P. 210.00K sh · $21.02M · Q3 2026
- First Turn Management, LLC 171.51K sh · $17.16M · Q3 2026
- Trails Edge Capital Partners, LP 170.00K sh · $17.01M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held INBX?
Cormorant Asset Management, LP has disclosed INBX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Cormorant Asset Management, LP's current position in INBX?
As of Q3 2026, Cormorant Asset Management, LP holds 50.00K shares of INBX (INHIBRX BIOSCIENCES INC), valued at $5.00M, representing 0.36% of its reported portfolio and ranking #39.
Has Cormorant Asset Management, LP been buying or selling INBX?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in INBX.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.